These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3263541)
21. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus. Tron F; Jacob L; Bach JF Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347 [No Abstract] [Full Text] [Related]
22. Pathogenesis of connective tissue disease. Holborow EJ Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889 [No Abstract] [Full Text] [Related]
23. [Eye involvement in inflammatory systemic diseases of connective tissue]. Böke W; Fischer C; Gartner J; Scheiffarth F Ber Zusammenkunft Dtsch Ophthalmol Ges; 1970; 70():396-424. PubMed ID: 4928992 [No Abstract] [Full Text] [Related]
28. [Incidence of antinuclear factors, studied by immunofluorescence, of 563 blood samples of subjects with collagen diseases and other disease states]. Del Giacco GS; Mignone V; Davoli C; Novi C Reumatismo; 1966; 18(3):146-50. PubMed ID: 5338008 [No Abstract] [Full Text] [Related]
30. [Participation of autoimmune and autoaggressive reactions in the mechanism of connective tissue disorganization]. Beglarian AG; Aznaurian AV Arkh Patol; 1970; 32(7):62-7. PubMed ID: 4099861 [No Abstract] [Full Text] [Related]
31. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies]. Damilano G; Hübscher O; Fernández L; Arana RM Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438 [No Abstract] [Full Text] [Related]
32. [Pathomechanisms of tissue damage exemplified by collagenoses]. Kalden JR; Krapf F Verh Dtsch Ges Inn Med; 1987; 93():93-7. PubMed ID: 3502054 [No Abstract] [Full Text] [Related]
33. Clinical significance of screening for antibody to ribonucleoprotein. Small P; Barrett D; Champlin E Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365 [TBL] [Abstract][Full Text] [Related]
34. [Detection of anti-nucleoprotein antibodies in mesenchymal and other diseases. Analysis of 110 cases]. Gonzalez Folch M; Saffie F; Gordillo H; Vergara A Rev Med Chil; 1971 Mar; 99(3):224-7. PubMed ID: 5315368 [No Abstract] [Full Text] [Related]
35. [Value of cutaneous immunofluorescence in the etiological diagnosis of a disease with antinuclear antibodies]. Lévêque E; Dréno B; Planchon B; Bureau B; Litoux P; Barrière H Ann Dermatol Venereol; 1986; 113(8):655-64. PubMed ID: 3541758 [No Abstract] [Full Text] [Related]
39. [Immunohistochemical research in diffuse reactive mesenchymopathies. Results and interpretative speculations]. Grimaldi MG Recenti Prog Med; 1969 Feb; 46(2):133-69. PubMed ID: 4893918 [No Abstract] [Full Text] [Related]
40. [Descriptive and comparative study of technical methods used for the detection of antinuclear antibodies]. Abuaf N Ann Biol Clin (Paris); 1982; 40(2):65-74. PubMed ID: 6812470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]